| 2932.99.39 | 00 | Benzointetrahydropyranyl ester; and Xanthen-9-one | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4￠/kg + 39.5% |
| 2932.99.55 | 00 | Bis-O-[(4-methylphenyl)methylene]-D- glucitol (Dimethylbenzylidene sorbitol); and Rhodamine 2C base | kg | Free | | 15.4￠/kg + 52% |
| 2933.11.00 | 00 | Compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.11.00 | 00 | Phenazone (Antipyrine) and its derivatives | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 15.4￠/kg + 49.5% |
| 2933.19.04 | 00 | Aminomethylphenylpyrazole (Phenylmethylaminopyrazole); and 3-Methyl-1-(p-tolyl)-2-pyrazolin-5-one (p-Tolyl methyl pyrazolone) | kg | Free | | 15.4￠/kg + 39.5% |
| 2933.19.08 | 00 | 3-(5-Amino-3-methyl-1H-pyrazol-1-yl)- benzenesulfonic acid; Amino-J-pyrazolone; 3-Amino-1-(2,4,6-trichlorophenyl)-5- pyrazolone; 3-Carboxy-1,4-sulfophenylpyrazol-5-one; 4-Chloro-3-(3-methyl-5-oxo-2-pyrazolin-1- yl)benzenesulfonic acid; 1-(m-Chlorophenyl)-3-methyl-2-pyrazolin- 5-one; p-Chloropyrazolone; 1-(2',5'-Dichlorophenyl)-3-methyl-2- pyrazolin-5-one; 1-(o-Ethylphenyl)-3-methyl-2-pyrazolin- 5-one; 5-Imino-3-methyl-1-phenylpyrazole; 5-Imino-3-methyl-1-(m-sulfophenyl)- pyrazole; 2,4-Methylcarboxypyrazolic acid; Methylphenylpyrazolone; and Sulfinpyrazone | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P,SG) | 15.4￠/kg + 39.5% |
| 2933.19.15 | 00 | 1,2-Dimethyl-3,5-diphenyl-1H-pyrazolium methyl sulfate (Difenzoquat methyl sulfate) | kg | Free | | 15.4￠/kg + 48.5% |
| 2933.19.18 | 00 | 2-Chloro-5-sulfophenylmethylpyrazolone; 2,5-Dichloro-4-(3-methyl-5-oxo-2- pyrazolin-1-yl) benzenesulfonic acid; Phenylcarbethoxypyrazolone; m-Sulfaminopyrazolone (m-Sulfamido- phenylmethylpyrazolone); and 1-(p-Sulfophenyl)-3-methylpyrazolone | kg | Free | | 15.4￠/kg + 52% |
| 2933.19.70 | 00 | 3-Methyl-5-pyrazolone | kg | Free | | 30.5% |
| 2933.21.00 | 00 | Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.29.05 | 00 | 1-[1-((4-Chloro-2-(trifluoromethyl)phenyl)- imino)-2-propoxyethyl]-1H-imidazole (Triflumizole); and Ethylene thiourea | kg | Free | | 15.4￠/kg + 52% |
| 2933.29.10 | 00 | 2-Phenylimidazole | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4￠/kg + 39.5% |
| 2933.29.60 | 00 | Imidazole | kg | Free | | 30.5% |
| 2933.33.00 | 00 | Alfentanil (INN), anileridine (INN), bezitramide (INN), bromazepam (INN), difenoxin (INN), diphenoxylate (INN), dipipanone (INN), fentanyl (INN), ketobemidone (INN), methylphenidate (INN), pentazocine (INN), pethidine (INN), pethidine (INN) intermediate A, phencyclidine (INN) (PCP), phenoperidine (INN), pipradrol (INN), piritramide (INN), propiram (INN) and trimeperidine (INN); salts thereof | kg | Free | | 15.4￠/kg + 149.5% |
| 2933.39.20 | 00 | p-Chloro-2-benzylpyridine; 4-Chloro-1-methylpiperidine hydrochloride; 1,4-Dimethyl-6-hydroxy-3-cyanopyrid-2-one; Di-(2,2,6,6-tetramethyl-4-hydroxy- piperidine)sebacate; 2-Methyl-5-ethylpyridine; 4-Phenylpropylpyridine; α-Phenylpyridylacetic acid, methyl ester; Picolinic acid; 2-Pyridinecarboxaldehyde; and 2,5-Pyridinedicarboxylic acid | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 39.5% |
| 2933.39.31 | 00 | Antidepressants, tranquilizers and other psychotherapeutic agents | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 3.1% (SG) | 15.4￠/kg + 149.5% |
| 2933.39.61 | 10 | 3-Quinuclidinyl benzilate | kg | | | |
| 2933.52 | | Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure: | | | | |
| 2933.55.00 | 00 | Loprazolam (INN), mecloqualone (INN), methaqualone (INN) and zipeprol (INN); salts thereof | kg | Free | | 15.4￠/kg + 149.5% |
| 2933.59.22 | 00 | Nicarbazin; and Trimethoprim | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 46% |
| 2933.59.46 | 00 | Antidepressants, tranquilizers and other psychotherapeutic agents | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 3.1% (SG) | 15.4￠/kg + 149.5% |
| 2933.61.00 | 00 | Compounds containing an unfused triazine ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.69.20 | 00 | 2,4-Diamino-6-phenyl-1,3,5-triazine | kg | Free | | 25% |
| 2933.72.00 | 00 | Clobazam (INN) and methyprylon (INN) | kg | Free | | 15.4￠/kg + 52% |
| 2933.91.00 | 00 | Alprazolam (INN), camazepam (INN), chlordiazepoxide (INN), clonazepam (INN), clorazepate, delorazepam (INN), diazepam (INN), estazolam (INN), ethyl loflazepate (INN), fludiazepam (INN), flunitrazepam (INN), flurazepam (INN), halazepam (INN), lorazepam (INN), lormetazepam (INN), mazindol (INN), medazepam (INN), midazolam (INN), nimetazepam (INN), nitrazepam (INN), nordazepam (INN), oxazepam (INN), pinazepam (INN), prazepam (INN), pyrovalerone (INN), temazepam (INN), tetrazepam (INN) and triazolam (INN); salts thereof | kg | Free | | 15.4￠/kg + 149.5% |
